These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 16735256)

  • 21. Status of newborn screening programs in the United States.
    Therrell BL; Johnson A; Williams D
    Pediatrics; 2006 May; 117(5 Pt 2):S212-52. PubMed ID: 16735250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Completeness and complexity of information available to parents from newborn-screening programs.
    Fant KE; Clark SJ; Kemper AR
    Pediatrics; 2005 May; 115(5):1268-72. PubMed ID: 15867034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Newborn screening expands: recommendations for pediatricians and medical homes--implications for the system.
    American Academy of Pediatrics Newborn Screening Authoring Committee
    Pediatrics; 2008 Jan; 121(1):192-217. PubMed ID: 18166575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient advocacy in newborn screening: continuities and discontinuities.
    Paul DB
    Am J Med Genet C Semin Med Genet; 2008 Feb; 148C(1):8-14. PubMed ID: 18200523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ACOG Committee Opinion No. 393, December 2007. Newborn screening.
    American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2007 Dec; 110(6):1497-500. PubMed ID: 18055755
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Newborn screening: current status.
    Arn PH
    Health Aff (Millwood); 2007; 26(2):559-66. PubMed ID: 17339686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Report of the Tennessee Task Force on Screening Newborn Infants for Critical Congenital Heart Disease.
    Liske MR; Greeley CS; Law DJ; Reich JD; Morrow WR; Baldwin HS; Graham TP; Strauss AW; Kavanaugh-McHugh AL; Walsh WF;
    Pediatrics; 2006 Oct; 118(4):e1250-6. PubMed ID: 17015513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. State newborn screening in the tandem mass spectrometry era: more tests, more false-positive results.
    Tarini BA; Christakis DA; Welch HG
    Pediatrics; 2006 Aug; 118(2):448-56. PubMed ID: 16882794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Every child is priceless: debating effective newborn screening policy.
    Howell RR
    Hastings Cent Rep; 2009; 39(1):4-6; author reply 7-8. PubMed ID: 19213181
    [No Abstract]   [Full Text] [Related]  

  • 30. Recommendations for effective newborn screening communication: results of focus groups with parents, providers, and experts.
    Davis TC; Humiston SG; Arnold CL; Bocchini JA; Bass PF; Kennen EM; Bocchini A; Kyler P; Lloyd-Puryear M
    Pediatrics; 2006 May; 117(5 Pt 2):S326-40. PubMed ID: 16735260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Newborn screening in Australia and New Zealand.
    Webster D; ;
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():69-70. PubMed ID: 15906698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current status of newborn screening: decision-making about the conditions to include in screening programs.
    Watson MS
    Ment Retard Dev Disabil Res Rev; 2006; 12(4):230-5. PubMed ID: 17183572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethical, legal, and social concerns about expanded newborn screening: fragile X syndrome as a prototype for emerging issues.
    Bailey DB; Skinner D; Davis AM; Whitmarsh I; Powell C
    Pediatrics; 2008 Mar; 121(3):e693-704. PubMed ID: 18310190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the new criteria for newborn screening.
    Botkin JR
    Health Matrix Clevel; 2009; 19(1):163-86. PubMed ID: 19459543
    [No Abstract]   [Full Text] [Related]  

  • 35. Screening for critical congenital heart disease: advancing detection in the newborn.
    Bradshaw EA; Martin GR
    Curr Opin Pediatr; 2012 Oct; 24(5):603-8. PubMed ID: 22935755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of neonatal screening for medium chain acyl-CoA dehydrogenase deficiency: the homogeneous population of The Netherlands.
    van der Hilst CS; Derks TG; Reijngoud DJ; Smit GP; TenVergert EM
    J Pediatr; 2007 Aug; 151(2):115-20, 120.e1-3. PubMed ID: 17643759
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Challenges and opportunities in establishing and maintaining newborn screening systems.
    Therrell BL
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():6-12. PubMed ID: 15906685
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Criteria supporting the study of drugs in the newborn.
    Ward RM; Benitz WE; Benjamin DK; Blackmon L; Giacoia GP; Hudak M; Lasky T; Rodriguez W; Selen A
    Clin Ther; 2006 Sep; 28(9):1385-98. PubMed ID: 17062311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mass neonatal screening using biological testing].
    Ardaillou R; Le Gall JY;
    Gynecol Obstet Fertil; 2007 Apr; 35(4):367-74. PubMed ID: 17400505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expanding metabolic screening of newborns: can the health care industry do better than public health?
    Mulvihill JJ; Blackett PR; Palmer SE
    J Okla State Med Assoc; 2003 Oct; 96(10):477-81. PubMed ID: 14619602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.